Nutex Health Inc. Securities Lawsuit Investigation

Shamis & Gentile P.A., a law firm that advocates for investors who are victims of securities fraud, is investigating potential claims against Nutex Health Inc. (NUTX).

If you purchased or held Nutex Health securities and suffered losses, you may be eligible to join this securities investigation and seek compensation.

About Nutex Health

Nutex Health operates a network of micro-hospitals and healthcare facilities across the United States.

During the period from July 2024 to July 2025, Nutex Health experienced significant growth in both revenue and stock price. The company reported substantial increases in insurer payments and highlighted the impact of its arbitration strategy under the No Surprises Act as a key driver of this growth.

Potential Items Under Investigation

Lawyers are investigating whether Nutex Health may have made misleading statements or omitted key information regarding its arbitration strategy and revenue growth during the class period of July 1, 2024 through July 23, 2025. One area of focus is the company’s repeated public statements about its use of arbitration under the No Surprises Act to increase insurer payments. For example, CEO Tom Vo stated on the Q2 2024 call, that Nutex Health had “already begun to engage in the arbitration process” and cited industry data suggesting providers were “prevailing 70% to 80% of the time in arbitration”. In subsequent financial reports, Nutex Health credited its arbitration strategy with driving significant revenue gains, such as reporting $479.9 million in revenue for 2024 and $211.8 million in Q1 2025, with arbitration accounting for approximately 73% of the increase.

However, the investigation may focus on whether Nutex Health adequately disclosed the role of its third-party arbitration vendor, HaloMD, and any associated legal risks. The Blue Orca short-seller report released on July 22, 2025, publicly alleged that Nutex Health’s growth was driven by a fraudulent billing scheme involving HaloMD. This report cited federal lawsuits accusing HaloMD of orchestrating a fraud and racketeering scheme to siphon millions from insurers on behalf of clients like Nutex Health. Legal professionals may examine whether Nutex Health’s public statements about its arbitration success were misleading in light of these allegations, especially since the company’s filings and press releases seemingly did not mention the specific vendor or the existence of lawsuits against HaloMD.

The market’s reaction to the Blue Orca report was immediate and severe. Nutex Health’s stock price fell approximately 10% on July 22, 2025, and another 7% on July 23, closing at $92.90 after having traded as high as $176 in May 2025. With around 5.5 million shares outstanding, these declines represent a loss of roughly $450 million in market value from the peak to the post-disclosure price.

The investigation may also review whether the company’s risk disclosures were sufficient, as Nutex Health’s filings mentioned general risks related to arbitration but did not address the specific legal challenges or vendor issues that later came to light.

Your Rights and Next Steps

If you purchased Nutex Health securities between July 1, 2024 and July 23, 2025, and suffered financial losses, you may have important legal rights. This is currently an investigation, not a filed class action lawsuit. Lawyers are gathering information to determine whether a lawsuit should be filed on behalf of investors.

Investors who join the investigation may help strengthen the case and increase the likelihood of recovering losses if a class action is later filed. Participation at this stage does not obligate you to anything, but it ensures that your interests are represented if the matter proceeds to litigation.

Lawyers are ready to help investors understand their options and guide them through the process. If you have documentation of your Nutex Health purchases and losses, you may submit this information as part of the investigation.

You May Be Entitled to Compensation

Securities investigations are time-sensitive. If you purchased or held Nutex Health securities and experienced losses during the class period, you may be eligible to join any potential class action and seek compensation for your losses.

To protect your rights and ensure you are included in any future recovery, complete the form below to join the investigation.